CAV2 and breast carcinoma: CAV1 and CAV2 also elucidated independent predicting value in the RFS of ER+ breast cancer patients, but the prognosis of breast cancer patients with other receptor status was not well differentiated by expression levels of CAV1 and CAV2 (Table 4 and Figure S3).